BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23832143)

  • 1. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.
    Manos J; Hu H; Rose BR; Wainwright CE; Zablotska IB; Cheney J; Turnbull L; Whitchurch CB; Grimwood K; Harmer C; Anuj SN; Harbour C;
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1583-92. PubMed ID: 23832143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
    Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran.
    Faraji F; Mahzounieh M; Ebrahimi A; Fallah F; Teymournejad O; Lajevardi B
    Microb Pathog; 2016 Oct; 99():1-4. PubMed ID: 27457974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.
    Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K;
    J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
    Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
    Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dimorphism in the microbiology of the CF 'Gender Gap': Estrogen modulation of Pseudomonas aeruginosa virulence.
    Tyrrell J; Harvey BJ
    Steroids; 2020 Apr; 156():108575. PubMed ID: 31901423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
    Ciragil P; Söyletir G
    Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
    Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
    PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of D-amino acid dehydrogenase on virulence factor production by a Pseudomonas aeruginosa.
    Oliver KE; Silo-Suh L
    Can J Microbiol; 2013 Sep; 59(9):598-603. PubMed ID: 24011342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain.
    Hare NJ; Solis N; Harmer C; Marzook NB; Rose B; Harbour C; Crossett B; Manos J; Cordwell SJ
    BMC Microbiol; 2012 Jan; 12():16. PubMed ID: 22264352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.
    Mayer-Hamblett N; Rosenfeld M; Gibson RL; Ramsey BW; Kulasekara HD; Retsch-Bogart GZ; Morgan W; Wolter DJ; Pope CE; Houston LS; Kulasekara BR; Khan U; Burns JL; Miller SI; Hoffman LR
    Am J Respir Crit Care Med; 2014 Aug; 190(3):289-97. PubMed ID: 24937177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.